Company profile: Nanosphere
1.1 - Company Overview
Company description
- Provider of a nanotechnology-based molecular diagnostics platform and clinical tests for genomic and protein testing and analysis. Instruments use microfluidics to pull DNA and proteins, delivering results in hours rather than days or weeks, with sensitivity two to three times higher than common hospital lab tests and much simpler.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanosphere
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
Polyganics
HQ: The Netherlands
Website
- Description: Provider of bioresorbable medical devices for natural tissue repair and regeneration, developing, manufacturing, and marketing products including LIQOSEAL dura sealant patch for watertight dural closure; dental and bone grafting materials such as GUIDOR easy-graft, MatrixDerm, MatrixOss Granules, and SynOss Putty; and dural repair solutions like DuraMatrix-Onlay Plus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polyganics company profile →
Teneobio
HQ: United States
Website
- Description: Provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRat™.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Teneobio company profile →
US BioTek
HQ: United States
Website
- Description: Provider of CLIA-accredited immunology and chemistry testing services for clinicians worldwide, including food sensitivity (IgG, IgG4, IgA), food allergy (IgE), inhalant/aeroallergen (IgG, IgG4, IgA, IgE), microbiome, organic acids, and environmental pollutants testing, backed by over 30 years of experience in ELISA technology. Headquartered in Shoreline, Washington.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US BioTek company profile →
Newcells Biotech
HQ: United Kingdom
Website
- Description: Provider of induced pluripotent stem cells (iPSCs) and their differentiated, reliable and reproducible cell and tissue types to support drug discovery, pre-clinical development, and disease mechanism investigation, including a physiologically relevant human small airway epithelial cell model that uses an air-liquid interface for research and drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newcells Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanosphere
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanosphere
2.2 - Growth funds investing in similar companies to Nanosphere
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanosphere
4.2 - Public trading comparable groups for Nanosphere
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →